IL107211A - Sealant compositions containing a fibrin monomer and methods and kits utilizing the same - Google Patents

Sealant compositions containing a fibrin monomer and methods and kits utilizing the same

Info

Publication number
IL107211A
IL107211A IL107211A IL10721193A IL107211A IL 107211 A IL107211 A IL 107211A IL 107211 A IL107211 A IL 107211A IL 10721193 A IL10721193 A IL 10721193A IL 107211 A IL107211 A IL 107211A
Authority
IL
Israel
Prior art keywords
methods
same
compositions containing
sealant compositions
fibrin monomer
Prior art date
Application number
IL107211A
Other languages
English (en)
Other versions
IL107211A0 (en
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of IL107211A0 publication Critical patent/IL107211A0/xx
Publication of IL107211A publication Critical patent/IL107211A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/005—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters containing a biologically active substance, e.g. a medicament or a biocide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/225—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/06—Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL107211A 1992-10-08 1993-10-08 Sealant compositions containing a fibrin monomer and methods and kits utilizing the same IL107211A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95821292A 1992-10-08 1992-10-08

Publications (2)

Publication Number Publication Date
IL107211A0 IL107211A0 (en) 1994-01-25
IL107211A true IL107211A (en) 1997-09-30

Family

ID=25500729

Family Applications (1)

Application Number Title Priority Date Filing Date
IL107211A IL107211A (en) 1992-10-08 1993-10-08 Sealant compositions containing a fibrin monomer and methods and kits utilizing the same

Country Status (24)

Country Link
US (12) US5750657A (fr)
EP (2) EP1266666A3 (fr)
JP (1) JP3771284B2 (fr)
KR (1) KR940008697A (fr)
CN (1) CN1091315A (fr)
AT (1) ATE244581T1 (fr)
AU (1) AU676201B2 (fr)
BR (1) BR9304185A (fr)
CA (3) CA2108104C (fr)
CZ (1) CZ211793A3 (fr)
DE (1) DE69333080T2 (fr)
DK (1) DK0592242T3 (fr)
ES (2) ES2202306T3 (fr)
FI (1) FI110616B (fr)
HU (1) HU218898B (fr)
IL (1) IL107211A (fr)
MX (1) MX9306272A (fr)
NO (1) NO314412B1 (fr)
NZ (3) NZ280264A (fr)
PL (3) PL175443B1 (fr)
PT (1) PT592242E (fr)
RU (1) RU2143924C1 (fr)
SG (1) SG49640A1 (fr)
SK (1) SK109393A3 (fr)

Families Citing this family (251)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6117425A (en) 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US7208179B1 (en) * 1990-11-27 2007-04-24 The American National Red Cross Methods for treating disease and forming a supplemented fibrin matrix
CN1091315A (zh) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
US6241747B1 (en) 1993-05-03 2001-06-05 Quill Medical, Inc. Barbed Bodily tissue connector
US8795332B2 (en) 2002-09-30 2014-08-05 Ethicon, Inc. Barbed sutures
ZA948564B (en) * 1993-11-19 1995-07-26 Bristol Myers Squibb Co Liquid separation apparatus and method
CA2188647A1 (fr) * 1994-05-02 1995-11-09 Stewart Anthony Cederholm-Williams Chaines de fibrine de recombinaison, fibrine et homologues de fibrine
AU695602B2 (en) * 1994-12-02 1998-08-20 Vivolution A/S Centrifuge reagent delivery system
US5733446A (en) * 1994-12-02 1998-03-31 Bristol-Myers Squibb Company Centrifuge with annular filter
US6946079B1 (en) * 1994-12-02 2005-09-20 Bristol-Myers Squibb Company Centrifugal filtration method for separating fibrin monomer from blood
CN1083284C (zh) * 1994-12-02 2002-04-24 布里斯托尔-迈尔斯斯奎布公司 从血浆中分离纤维蛋白的方法和设备
US5605541A (en) 1994-12-07 1997-02-25 E. R. Squibb And Sons, Inc. Fibrin sealant applicatoor
US5585007A (en) * 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
ATE244584T1 (de) * 1995-01-16 2003-07-15 Baxter Int Selbsttragende flächengebilde aus vernetztem fibrin zur hemmung von postoperativen adhäsionen
US5733545A (en) * 1995-03-03 1998-03-31 Quantic Biomedical Partners Platelet glue wound sealant
US6551794B1 (en) * 1995-11-09 2003-04-22 E. R. Squibb & Sons, Inc. Stable biotinylated biomolecule composition
US5691152A (en) * 1995-11-09 1997-11-25 E. R. Squibb & Sons, Inc. Stable avidin composition
IL124672A0 (en) 1995-12-07 1998-12-06 Bristol Myers Squibb Co A device and method for applying a mixture of two liquid components
WO2000062828A1 (fr) 1996-04-30 2000-10-26 Medtronic, Inc. Fibrine autologue d'obturation et ses methodes de fabrication
WO1997040864A1 (fr) * 1996-04-30 1997-11-06 Medtronic, Inc. Procede pour fabriquer une substance de scellage autologue en fibrine
WO1998002098A1 (fr) 1996-07-12 1998-01-22 Baxter International Inc. Dispositif distributeur de fibrine et procede de formation de fibrine sur une surface
DE19634313A1 (de) * 1996-08-24 1998-02-26 Behringwerke Ag Methode zur Stabilisierung von Plättchen
US5844087A (en) * 1996-11-05 1998-12-01 Bayer Corporation Method and device for delivering fibrin glue
WO1998020931A1 (fr) 1996-11-15 1998-05-22 Bristol-Myers Squibb Company Dispositifs et procedes utilises pour appliquer un melange de deux composants liquides ou davantage pour former un biomateriau
US6613020B1 (en) 1996-12-06 2003-09-02 Bristol-Myers Squibb Company Method of applying a mixture of two liquid components as well as a device for carrying out the method
FR2757770B1 (fr) * 1996-12-30 1999-02-26 Inoteb Procede de preparation d'une colle biologique capable de coaguler par simple addition d'ions calcium
WO1998030887A1 (fr) 1997-01-08 1998-07-16 Bristol-Myers Squibb Company Appareil et procedes de preparation de solutions a base de sang ou de plasma a concentration connue
US6132598A (en) * 1997-01-08 2000-10-17 Bristol-Myers Squibb Company Centrifuge apparatus with temperature control means
WO1998030331A1 (fr) * 1997-01-08 1998-07-16 Bristol-Myers Squibb Company Centrifugeuse pour la separation du sang
WO1998042260A1 (fr) 1997-03-27 1998-10-01 Bristol-Myers Squibb Company Applicateur laparoscopique de matiere obturante
US5971956A (en) * 1997-04-15 1999-10-26 Biosurgical Corporation Medical suctioning apparatus and methods of use
US6331172B1 (en) 1997-04-14 2001-12-18 Baxter International Inc. Applicator for dispensing measured quantities with use of controlled suction
US5931855A (en) 1997-05-21 1999-08-03 Frank Hoffman Surgical methods using one-way suture
GB9711927D0 (en) * 1997-06-09 1997-08-06 Bristol Myers Squibb Co Compositions useful as fibrin sealants
IT1292410B1 (it) * 1997-06-24 1999-02-08 Roberto Beretta Contenitore di pronto impiego per ottenere colla di fibrina autologa
US7745106B2 (en) 1997-06-24 2010-06-29 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components
US6979307B2 (en) 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
ZA987019B (en) * 1997-08-06 1999-06-04 Focal Inc Hemostatic tissue sealants
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
AU1808999A (en) 1997-12-09 1999-06-28 Bristol-Myers Squibb Company Fibrinolytic inhibitor for sealant
WO1999029838A1 (fr) * 1997-12-09 1999-06-17 Bristol-Myers Squibb Company Hybrides d'enzymes de conversion du fibrinogene
US6159232A (en) 1997-12-16 2000-12-12 Closys Corporation Clotting cascade initiating apparatus and methods of use and methods of closing wounds
US6478808B2 (en) * 1997-12-17 2002-11-12 Closys Corporation Clotting cascade initiating apparatus and methods of use and methods of closing wounds
US6762336B1 (en) 1998-01-19 2004-07-13 The American National Red Cross Hemostatic sandwich bandage
NZ507786A (en) * 1998-05-06 2002-10-25 Bristol Myers Squibb Co Directional endoscopic delivery of material
US20020022588A1 (en) * 1998-06-23 2002-02-21 James Wilkie Methods and compositions for sealing tissue leaks
US6083383A (en) * 1998-06-25 2000-07-04 Huang; Xun Yang Apparatus for production of fibrin ogen or fibrin glue
US6274090B1 (en) 1998-08-05 2001-08-14 Thermogenesis Corp. Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby
JP2000070241A (ja) * 1998-08-31 2000-03-07 Nissho Corp 急速凝固用真空採血管
BE1012536A3 (fr) 1998-11-04 2000-12-05 Baxter Int Element muni d'une couche de fibrine sa preparation et son utilisation.
CA2350628A1 (fr) * 1998-11-12 2000-05-18 Polymer Biosciences, Inc. Polymere hemostatique permettant une coagulation sanguine rapide et l'hemostase
AU773128B2 (en) * 1998-11-18 2004-05-20 Csl Behring Gmbh Stabilised protein preparations for a tissue adhesive
DE19853033A1 (de) * 1998-11-18 2000-05-25 Centeon Pharma Gmbh Stabilisierte Proteinzubereitung für einen Gewebekleber
DE10025001A1 (de) * 2000-05-22 2001-11-29 Aventis Behring Gmbh Gewebekleber mit verbesserten anti-adhäsiven Eigenschaften
US7276235B2 (en) * 1998-11-18 2007-10-02 Zlb Behring Gmbh Tissue glue with improved antiadhesive properties
JP2002531176A (ja) * 1998-12-02 2002-09-24 ブリストル−マイヤーズ スクイブ カンパニー 細胞の噴霧輸送
DE19858463A1 (de) * 1998-12-18 2000-06-21 Centeon Pharma Gmbh Verwendung eines Fibrinklebers zur Regeneration des Lebergewebes
US6310036B1 (en) 1999-01-09 2001-10-30 Last Chance Tissue Adhesives Corporation High strength, Bio-compatible tissue adhesive and methods for treating vigorously bleeding surfaces
US7015198B1 (en) 1999-05-11 2006-03-21 Orentreich Foundation For The Advancement Of Science, Inc. Materials for soft tissue augmentation and methods of making and using same
US6921412B1 (en) 1999-05-18 2005-07-26 Cryolife, Inc. Self-supporting, shaped, three-dimensional biopolymeric materials and methods
AT500670A1 (de) * 1999-05-19 2006-02-15 Bio & Bio Licensing Sa Arzneimittel zur lokalen anwendung
WO2000072856A1 (fr) * 1999-06-01 2000-12-07 Bristol-Myers Squibb Company Agents d'obturation a base de fibrine declenchant une moindre reponse inflammatoire; methodes d'utilisation
WO2000072857A1 (fr) 1999-06-01 2000-12-07 Bristol-Myers Squibb Company Structure polymere de fibrine
CA2373704A1 (fr) * 1999-06-01 2000-12-07 Bristol-Myers Squibb Company Prevention d'adherences post-chirurgicales utilisant un scellement de monomere de fibrine
US6472162B1 (en) 1999-06-04 2002-10-29 Thermogenesis Corp. Method for preparing thrombin for use in a biological glue
EP1208212A4 (fr) * 1999-06-16 2007-05-02 Bristol Myers Squibb Co Materiau d'obturation a base de fibrine utilise comme vehicule de transfection/transformation destine a la therapie genique
US6610043B1 (en) * 1999-08-23 2003-08-26 Bistech, Inc. Tissue volume reduction
US7654998B1 (en) * 1999-08-23 2010-02-02 Aeris Therapeutics, Inc. Tissue volume reduction
CA2316554C (fr) 1999-08-25 2007-10-23 Bristol-Myers Squibb Company Applicateur et systeme d'entrainement d'applicateur electromecanique
US6463335B1 (en) 1999-10-04 2002-10-08 Medtronic, Inc. Temporary medical electrical lead having electrode mounting pad with biodegradable adhesive
EP1242157B1 (fr) * 1999-10-29 2005-01-12 Bristol-Myers Squibb Company Appareil et procedes permettant de preparer des solutions de composants sanguins ou plasmatiques presentant des concentrations ameliorees
US6730313B2 (en) 2000-01-25 2004-05-04 Edwards Lifesciences Corporation Delivery systems for periadventitial delivery for treatment of restenosis and anastomotic intimal hyperplasia
US6187347B1 (en) 2000-02-09 2001-02-13 Ecosafe, Llc. Composition for arresting the flow of blood and method
JP3576063B2 (ja) * 2000-02-22 2004-10-13 株式会社ホギメディカル 凝固蛋白質を含む可溶性創傷治癒止血セルロース繊維とその製造方法
EP1155706A1 (fr) * 2000-05-19 2001-11-21 Xun Yang Huang Appareil pour la production de colle de fibrine et son application médicale
JP2004513676A (ja) * 2000-06-22 2004-05-13 オースティン，サム，エル 生体接着剤組成物及びその製造と使用
US6921532B1 (en) * 2000-06-22 2005-07-26 Spinal Restoration, Inc. Biological Bioadhesive composition and methods of preparation and use
AU2001292609A1 (en) * 2000-09-11 2002-03-26 Closure Medical Corporation Bronchial occlusion method and apparatus
EP1416946B1 (fr) * 2000-11-07 2017-12-20 CryoLife, Inc. Biomateriaux semblables a la mousse expansibles et procedes
US6942880B1 (en) * 2001-04-09 2005-09-13 Medtronic, Inc. Autologous platelet gel having beneficial geometric shapes and methods of making the same
US7795218B2 (en) 2001-04-12 2010-09-14 Bioaxone Therapeutique Inc. ADP-ribosyl transferase fusion variant proteins
EP1406678B1 (fr) * 2001-04-25 2009-01-14 Eidgenössische Technische Hochschule Zürich Matrices pour l'administration de medicaments destinees a ameliorer la cicatrisation
US7056331B2 (en) 2001-06-29 2006-06-06 Quill Medical, Inc. Suture method
US6994722B2 (en) 2001-07-03 2006-02-07 Scimed Life Systems, Inc. Implant having improved fixation to a body lumen and method for implanting the same
US6848152B2 (en) 2001-08-31 2005-02-01 Quill Medical, Inc. Method of forming barbs on a suture and apparatus for performing same
US6692515B2 (en) * 2001-11-07 2004-02-17 Frank H. Boehm, Jr. Surgical kit for repairing leaks in fluid carrying vessels and organs and method thereof
US7101862B2 (en) * 2001-12-31 2006-09-05 Area Laboratories, Llc Hemostatic compositions and methods for controlling bleeding
DE10204405A1 (de) * 2002-02-04 2003-08-21 Surface Care Gmbh Plasmagel
AU2003225543A1 (en) * 2002-02-04 2003-09-02 Damage Control Surgical Technologies, Inc. Method and apparatus for improved hemostasis and damage control operations
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
AU2003249642A1 (en) 2002-05-24 2003-12-12 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US6773450B2 (en) 2002-08-09 2004-08-10 Quill Medical, Inc. Suture anchor and method
CN1327905C (zh) * 2002-09-10 2007-07-25 美国国家红十字会 止血敷料
US20040088003A1 (en) 2002-09-30 2004-05-06 Leung Jeffrey C. Barbed suture in combination with surgical needle
US8100940B2 (en) 2002-09-30 2012-01-24 Quill Medical, Inc. Barb configurations for barbed sutures
JP3640655B2 (ja) * 2002-10-23 2005-04-20 一知 井上 血管新生誘導剤
US20050004599A1 (en) * 2003-06-30 2005-01-06 Mcnally-Heintzelman Karen M. Non-light activated adhesive composite, system, and methods of use thereof
US7943810B2 (en) 2003-02-04 2011-05-17 Buckman Robert F Method and apparatus for hemostasis
JP4585743B2 (ja) * 2003-02-13 2010-11-24 独立行政法人物質・材料研究機構 生体内分解吸収性粘着性医用材料
US8394397B2 (en) * 2003-03-28 2013-03-12 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Adhesive antineoplastic compositions
US20040224006A1 (en) * 2003-04-21 2004-11-11 Samn Raffaniello Ancrod irradiated, impregnated or coated sutures and other first aid or wound management bandaging materials for minimizing scarring and/or preventing excessive scar formation
US7624487B2 (en) 2003-05-13 2009-12-01 Quill Medical, Inc. Apparatus and method for forming barbs on a suture
US20070073338A1 (en) * 2003-09-04 2007-03-29 Roy Raghunandan Supercutaneous method and device for promoting hemostasis in cannulated patient
AU2004273867B2 (en) 2003-09-12 2011-01-27 Marine Polymer Technologies, Inc. Vascular access preservation in hemodialysis patients
US20050075728A1 (en) 2003-10-06 2005-04-07 Nguyen Tuoc Tan Minimally invasive valve replacement system
EP1684671B1 (fr) 2003-10-06 2020-09-30 Medtronic 3F Therapeutics, Inc. Systeme de remplacement valvulaire minimalement effractif
EP2338441B1 (fr) 2003-12-11 2013-01-23 Isto Technologies Inc. Système chondral particulier
NZ598970A (en) 2004-05-14 2013-07-26 Ethicon Llc Suture device using an enlongated body with barbs and a needle at one end and an anchor to prevent pull-through at the other end
EP1759718A4 (fr) * 2004-05-21 2011-03-02 Chemo Sero Therapeut Res Inst Préparation de collage de tissu
US7670282B2 (en) 2004-06-14 2010-03-02 Pneumrx, Inc. Lung access device
US20050281798A1 (en) * 2004-06-16 2005-12-22 Glen Gong Targeting sites of damaged lung tissue using composition
US7678767B2 (en) 2004-06-16 2010-03-16 Pneumrx, Inc. Glue compositions for lung volume reduction
US20060004400A1 (en) 2004-06-16 2006-01-05 Mcgurk Erin Method of treating a lung
US20050281740A1 (en) * 2004-06-16 2005-12-22 Glen Gong Imaging damaged lung tissue
US7553810B2 (en) * 2004-06-16 2009-06-30 Pneumrx, Inc. Lung volume reduction using glue composition
US20050281739A1 (en) * 2004-06-16 2005-12-22 Glen Gong Imaging damaged lung tissue using compositions
US20050281799A1 (en) 2004-06-16 2005-12-22 Glen Gong Targeting damaged lung tissue using compositions
US7608579B2 (en) * 2004-06-16 2009-10-27 Pneumrx, Inc. Lung volume reduction using glue compositions
JP5113519B2 (ja) 2004-07-08 2013-01-09 ヌームアールエックス・インコーポレーテッド 胸膜滲出の治療装置，治療方法及び材料
US7766891B2 (en) 2004-07-08 2010-08-03 Pneumrx, Inc. Lung device with sealing features
US8124075B2 (en) * 2004-07-16 2012-02-28 Spinal Restoration, Inc. Enhanced biological autologous tissue adhesive composition and methods of preparation and use
US8403923B2 (en) * 2004-10-29 2013-03-26 Spinal Restoration, Inc. Injection of fibrin sealant in the absence of corticosteroids in spinal applications
US8419722B2 (en) * 2004-10-29 2013-04-16 Spinal Restoration, Inc. Apparatus and method for injection of fibrin sealant in spinal applications
US8206448B2 (en) 2004-10-29 2012-06-26 Spinal Restoration, Inc. Injection of fibrin sealant using reconstituted components in spinal applications
US7597687B2 (en) * 2004-10-29 2009-10-06 Spinal Restoration, Inc. Injection of fibrin sealant including an anesthetic in spinal applications
EP1804843B1 (fr) * 2004-10-18 2014-12-03 Covidien LP Structure de suture adhesive
US20060115455A1 (en) * 2004-10-22 2006-06-01 Reed Kenneth C Therapeutic RNAi agents for treating psoriasis
US20110213464A1 (en) * 2004-10-29 2011-09-01 Whitlock Steven I Injection of fibrin sealant in the absence of corticosteroids in spinal applications
CA2587857C (fr) 2004-11-23 2017-10-10 Pneumrx, Inc. Dispositif orientable destine a acceder a un site cible et procedes correspondants
ATE419019T1 (de) * 2005-01-14 2009-01-15 Eska Implants Gmbh & Co Verfahren zur herstellung einer osteoinduktiv- antiseptischen implantatbeschichtung
WO2006086201A2 (fr) 2005-02-07 2006-08-17 Hanuman Llc Appareil et procede de concentration de plasma riche en plaquettes
EP2666494B1 (fr) 2005-02-07 2018-01-17 Hanuman LLC Appareil et procédé de concentration de plasma riche en plaquettes
US7866485B2 (en) 2005-02-07 2011-01-11 Hanuman, Llc Apparatus and method for preparing platelet rich plasma and concentrates thereof
US7766900B2 (en) 2005-02-21 2010-08-03 Biomet Manufacturing Corp. Method and apparatus for application of a fluid
WO2007025290A2 (fr) 2005-08-26 2007-03-01 Isto Technologies, Inc. Implants et procedes pour la reparation, le remplacement et le traitement de maladies articulaires
US20070110788A1 (en) * 2005-11-14 2007-05-17 Hissong James B Injectable formulation capable of forming a drug-releasing device
RU2308287C2 (ru) * 2005-12-26 2007-10-20 Владимир Александрович Макаров Гемостатическое средство
US9402633B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
US8888800B2 (en) 2006-03-13 2014-11-18 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US8157837B2 (en) 2006-03-13 2012-04-17 Pneumrx, Inc. Minimally invasive lung volume reduction device and method
US20070248653A1 (en) * 2006-04-20 2007-10-25 Cochrum Kent C Hemostatic compositions and methods for controlling bleeding
WO2007127834A2 (fr) 2006-04-26 2007-11-08 Medtronic, Inc. Compositions et leurs méthodes d'élaboration
WO2007127390A2 (fr) * 2006-04-28 2007-11-08 Biolife, L.L.C. Matières et procédés pour le traitement de plaies
US20070264296A1 (en) * 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US7993675B2 (en) * 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US7959943B2 (en) * 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US7976873B2 (en) 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
AU2007281996B2 (en) * 2006-08-04 2013-06-27 Stb, Ltd Solid dressing for treating wounded tissue
DE07825069T1 (de) * 2006-09-07 2010-04-08 Ed Geistlich Söhne Ag Für Chemische Industrie Verfahren zur behandlung von knochenkrebs
US20100297218A1 (en) * 2006-09-20 2010-11-25 Pneumrx, Inc. Tissue adhesive compositions and methods thereof
US7968682B2 (en) * 2006-12-12 2011-06-28 Oregon Health & Science University Degradation-resistant fibrinogen sealants
US20080154233A1 (en) * 2006-12-20 2008-06-26 Zimmer Orthobiologics, Inc. Apparatus for delivering a biocompatible material to a surgical site and method of using same
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
EP2106263B1 (fr) * 2007-01-04 2016-12-21 Hepacore Ltd. Dérivés réactifs solubles dans l'eau de carboxy polysaccharides et conjugués à base de carboxy polysaccharides et du fibrinogène
US8088095B2 (en) * 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
GB2447012B (en) * 2007-02-21 2011-03-16 Pharmacure Health Care Ab Composition for combating epistaxis
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
AU2008240191B2 (en) 2007-04-12 2013-09-19 Zimmer, Inc. Compositions and methods for tissue repair
JP5479319B2 (ja) 2007-04-12 2014-04-23 バイオメット・バイオロジックス・リミテッド・ライアビリティ・カンパニー ブイ式懸濁液分画システム
US8915943B2 (en) 2007-04-13 2014-12-23 Ethicon, Inc. Self-retaining systems for surgical procedures
WO2009020612A1 (fr) * 2007-08-06 2009-02-12 Stb Lifesaving Technologies, Inc. Procédés et pansement pour refermer des plaies internes
ES2398779T3 (es) 2007-09-27 2013-03-21 Ethicon Llc Suturas de auto-retención que incluyen elementos de retención a tejido con resistencia mejorada
BRPI0820129B8 (pt) 2007-12-19 2021-06-22 Angiotech Pharm Inc processo de formação de uma sutura autorretentora e sutura autorretentora
US8916077B1 (en) 2007-12-19 2014-12-23 Ethicon, Inc. Self-retaining sutures with retainers formed from molten material
US8118834B1 (en) 2007-12-20 2012-02-21 Angiotech Pharmaceuticals, Inc. Composite self-retaining sutures and method
CA2710798A1 (fr) * 2007-12-28 2009-07-09 Kuros Biosurgery Ag Proteines hybrides du pdgf incorporees dans des mousses de fibrine
US8615856B1 (en) 2008-01-30 2013-12-31 Ethicon, Inc. Apparatus and method for forming self-retaining sutures
WO2009097556A2 (fr) 2008-01-30 2009-08-06 Angiotech Pharmaceuticals, Inc. Appareil et procédé de formation de sutures auto-statiques
WO2009105663A2 (fr) 2008-02-21 2009-08-27 Angiotech Pharmaceuticals, Inc. Procédé et appareil permettant de relever des éléments de rétention sur des sutures autorétentives
US8216273B1 (en) 2008-02-25 2012-07-10 Ethicon, Inc. Self-retainers with supporting structures on a suture
US8641732B1 (en) 2008-02-26 2014-02-04 Ethicon, Inc. Self-retaining suture with variable dimension filament and method
EP2259774B1 (fr) 2008-02-27 2012-12-12 Biomet Biologics, LLC Procédés et compositions pour administrer un antagoniste de récepteur d interleukine-1antagonist
US8337711B2 (en) 2008-02-29 2012-12-25 Biomet Biologics, Llc System and process for separating a material
US8518272B2 (en) 2008-04-04 2013-08-27 Biomet Biologics, Llc Sterile blood separating system
US20090259263A1 (en) 2008-04-11 2009-10-15 Biomet Microfixation, Inc. Apparatus and methods of fixating bone
JP5619726B2 (ja) 2008-04-15 2014-11-05 エシコン・エルエルシーEthicon, LLC 双方向リテーナ又は一方向リテーナを持つ自己保持縫合材
US8012077B2 (en) 2008-05-23 2011-09-06 Biomet Biologics, Llc Blood separating device
WO2009152374A2 (fr) 2008-06-12 2009-12-17 Medtronic Xomed, Inc. Procédé de traitement de plaies chroniques
US9173669B2 (en) 2008-09-12 2015-11-03 Pneumrx, Inc. Enhanced efficacy lung volume reduction devices, methods, and systems
US20100086576A1 (en) 2008-10-06 2010-04-08 Myntti Matthew F Antimicrobial composition and methods of making and using same
MX339174B (es) 2008-11-03 2016-05-12 Ethicon Llc Longitud de sutura autorretenible y metodo y dispositivo para su uso.
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8110208B1 (en) 2009-03-30 2012-02-07 Biolife, L.L.C. Hemostatic compositions for arresting blood flow from an open wound or surgical site
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US20100256671A1 (en) * 2009-04-07 2010-10-07 Biomedica Management Corporation Tissue sealant for use in noncompressible hemorrhage
WO2010129258A2 (fr) 2009-04-27 2010-11-11 Mallinckrodt Inc. Compositions de scellement tissulaire, dispositifs de fermeture vasculaire et utilisations de ceux-ci
CN102573700B (zh) 2009-05-18 2014-12-17 纽姆克斯股份有限公司 细长的肺减容装置在部署过程中的横截面变化
US8367802B2 (en) * 2009-06-18 2013-02-05 Biomedica Management Corporation Method to produce fibrin monomer in acid media for use as tissue sealant
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
WO2011040888A1 (fr) * 2009-10-01 2011-04-07 Singapore Health Services Pte Ltd Composition ou combinaison biodégradable et ses utilisations
US20110171285A1 (en) * 2009-10-28 2011-07-14 The Texas A&M University System Design of Fibrinogen and Fibrinogen Derived Products with Reduced Bacterial Binding by Using Modified Sequences of Fibrinogen Chains
WO2011090628A2 (fr) 2009-12-29 2011-07-28 Angiotech Pharmaceuticals, Inc. Sutures bidirectionnelles d'auto-retenue ayant des indices marqués au laser et/ou non marqués au laser et procédés associés
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
NZ705330A (en) 2010-05-04 2016-12-23 Ethicon Llc Laser cutting system and methods for creating self-retaining sutures
AU2011265232B2 (en) 2010-06-11 2015-01-22 Ethicon Llc Suture delivery tools for endoscopic and robot-assisted surgery and methods
US10231721B2 (en) 2010-06-24 2019-03-19 St. Croix Surgical Systems, Llc Failsafe percutaneous wound barrier
RU2608237C2 (ru) 2010-11-03 2017-01-17 ЭТИКОН ЭлЭлСи Самоудерживающиеся шовные материалы, выделяющие лекарственные средства, и относящиеся к ним методы
EP3138506B1 (fr) 2010-11-09 2020-08-26 Ethicon, LLC Sutures auto-rétentives d'urgence
US10492780B2 (en) 2011-03-23 2019-12-03 Ethicon, Inc. Self-retaining variable loop sutures
WO2012140650A2 (fr) 2011-04-12 2012-10-18 Hepacore Ltd. Conjugués de carboxy polysaccharides avec des facteurs de croissance des fibroblastes et variants de ceux-ci
EP2706845B1 (fr) 2011-05-10 2021-06-23 Next Science IP Holdings Pty Ltd Matériau solide antimicrobien et ses procédés de fabrication et d'utilisation
US20130172931A1 (en) 2011-06-06 2013-07-04 Jeffrey M. Gross Methods and devices for soft palate tissue elevation procedures
DE102011122227A1 (de) 2011-12-23 2013-06-27 Medizinische Hochschule Hannover Verfahren und Vorrichtung zur Herstellung eines bioartifiziellen Gewebekonstrukts
US20130202656A1 (en) 2012-02-03 2013-08-08 Dynasil Biomedical Corporation Systems and kits for the fabrication of tissue patches
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
RU2589648C2 (ru) 2012-09-25 2016-07-10 Стем Селл Партнерс Ллк Способ и устройство для получения сыворотки с тромбином от одного донора
US10016527B2 (en) 2012-10-23 2018-07-10 Orthovita, Inc. Materials and methods for repair of cartilage defects
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
EP2938275A1 (fr) * 2012-12-31 2015-11-04 George D. Falus Colle de fibrine sous forme lyophilisée pour hémorragie de grande abondance
US8906856B2 (en) * 2012-12-31 2014-12-09 Biomedica Mangement Corporation Single component fibrin hemostat
WO2014121000A1 (fr) * 2013-02-01 2014-08-07 Xcede Technologies, Inc. Chirurgie minimalement invasive, comprenant une fermeture vasculaire, et agents d'étanchéité associés
WO2014127047A1 (fr) 2013-02-12 2014-08-21 Replicel Life Sciences Inc. Compositions et méthodes pour traiter et réparer des tendons
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
RU2522879C1 (ru) * 2013-04-23 2014-07-20 ОАО "Научно-исследовательский институт текстильных материалов" (ОАО "НИИТМ") Биодеградируемое гемостатическое лекарственное средство для остановки капиллярных и паренхиматозных кровотечений
IL230151A0 (en) * 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing a polymerization inhibitor
IL230150A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing zymogens
WO2015123477A1 (fr) 2014-02-12 2015-08-20 Replicel Life Sciences Inc. Compositions et méthodes de traitement des os, des articulations et du cartilage
IL231230A0 (en) 2014-02-27 2014-08-31 Omrix Biopharmaceuticals Ltd Fibrinogen preparation
IL231792A0 (en) 2014-03-27 2014-08-31 Omrix Biopharmaceuticals Ltd Device and method for the preparation and administration of one-component fibrin glue
BR102014011436A8 (pt) * 2014-05-12 2018-01-09 Univ Estadual Paulista Julio De Mesquita Filho selante de fibrina para uso tópico, método de formação do mesmo e seu uso
US10390838B1 (en) 2014-08-20 2019-08-27 Pneumrx, Inc. Tuned strength chronic obstructive pulmonary disease treatment
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
US9713810B2 (en) 2015-03-30 2017-07-25 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9757721B2 (en) 2015-05-11 2017-09-12 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
EP3331577A4 (fr) 2015-08-07 2019-07-17 Xcede Technologies, Inc. Compositions adhésives et procédés associés
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
US10501715B1 (en) 2015-09-11 2019-12-10 Mark H. Widick System for the formation of fibrin foam
RU2628809C1 (ru) * 2016-06-30 2017-08-22 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения Российской Федерации (ФГБУ ГНЦ Минздрава России) Гемостатическая губка и способ ее получения
FR3055805B1 (fr) 2016-09-09 2020-05-15 Assistance Publique - Hopitaux De Paris (Ap-Hp) Biomateriau a usage therapeutique
CN108220233B (zh) * 2016-12-21 2021-07-09 上海透景诊断科技有限公司 细胞分离器具表面处理方法、相关器具、外周血稀有细胞或循环肿瘤细胞快速高效分离方法
CN107589246B (zh) * 2017-03-07 2019-10-01 上海原科实业发展有限公司 一种纤维蛋白激活剂、其制备方法，包括该激活剂的试剂盒及采用该试剂盒的检测方法
RU179063U1 (ru) * 2017-07-03 2018-04-25 Федеральное государственное бюджетное образовательное учреждение высшего образования "Амурская государственная медицинская академия" Министерства здравоохранения Российской Федерации Салфетка с фибрином
JP7110360B2 (ja) 2017-10-09 2022-08-01 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー 凍結乾燥方法
US11154637B2 (en) 2018-11-07 2021-10-26 Industrial Technology Research Institute Biodegradable sealant and use of a biodegradable sealant in manufacture of an agent for biological tissue adhesion or repair
CN109679946B (zh) * 2019-01-04 2020-11-13 宁波艾捷康宁生物科技有限公司 一种血液病毒rna保护剂及采血管
JP7471316B2 (ja) 2019-03-14 2024-04-19 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー マルチパート凍結乾燥容器
RU2749983C1 (ru) * 2020-11-09 2021-06-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Алтайский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ герметизации панкреато-кишечного анастомоза с применением фибринового композита
EP4274625A1 (fr) * 2021-01-07 2023-11-15 Baxter International Inc. Matériaux hémostatiques exempts de thrombine, procédés de fabrication et utilisations de ces derniers
WO2023222770A1 (fr) 2022-05-17 2023-11-23 Julius-Maximilians-Universitaet Wuerzburg Nouveaux variants de fibrinogène recombinant pour produits d'étanchéité à base de fibrine pour le soin des plaies chirurgicales

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533004A (en) * 1943-10-27 1950-12-05 John D Ferry Fibrin clots and methods for preparing the same
CH586233A5 (fr) * 1971-01-18 1977-03-31 Pentapharm Ag
GB1417003A (en) * 1972-06-22 1975-12-10 Radiochemical Centre Ltd Stabilisation of fibrinogen
US3915640A (en) * 1974-08-06 1975-10-28 Warner Lambert Co Method and composition for detecting fibrin monomers and fibrin degradation products
SU663404A1 (ru) * 1976-12-30 1979-05-25 Московский Ордена Ленина И Ордена Трудового Красного Знамени Государственный Университет Им. М.В.Ломоносова Способ получени фибрин-мономера
US4442650A (en) * 1977-12-15 1984-04-17 Sivachenko Eugene W Girder construction
US4167823A (en) * 1978-06-21 1979-09-18 Kumming Deborah G Coagulation puzzle for teaching coagulation theory
JPS5598196A (en) * 1979-01-16 1980-07-25 Meito Sangyo Kk Fractionation of fibrinogen or its constituents and their use
SE417342B (sv) * 1979-02-05 1981-03-09 Nya Asfalt Ab Forfarande och anordning for grundleggning av for tillverkade anleggningar i land
AT359653B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
DE3017707A1 (de) * 1980-05-08 1981-11-12 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und reagens zum nachweis von fibrinmonomer
US4488198A (en) * 1981-01-15 1984-12-11 Sundstrand Corporation Protective circuit for clutchless parallel generating system
US4455290A (en) * 1981-04-02 1984-06-19 Research Corporation Inhibition of fibrin polymerization by a peptide isolated from fibrin Fragment D1
US4495278A (en) * 1981-04-27 1985-01-22 Baxter Travenol Laboratories, Inc. Process for making novel blood clotting enzyme compositions
US4480029A (en) * 1981-04-27 1984-10-30 Baxter Travenol Laboratories, Inc. Biological indicators and their use
ATE20824T1 (de) * 1981-06-25 1986-08-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundheilung.
EP0068149A3 (fr) * 1981-06-25 1983-07-20 Serapharm GmbH & Co. KG Préparation sêche contenant du fibrinogène, son obtention et utilisation
US4442655A (en) * 1981-06-25 1984-04-17 Serapharm Michael Stroetmann Fibrinogen-containing dry preparation, manufacture and use thereof
DE3175003D1 (en) * 1981-06-25 1986-08-28 Serapharm Gmbh & Co Kg Enriched plasma derivative for promoting wound sealing and wound healing
US4438198A (en) * 1981-09-30 1984-03-20 Trimedyne, Inc. Biochemically active matrix for use in a bio-artificial organ
DE3203775A1 (de) * 1982-02-04 1983-08-11 Behringwerke Ag, 3550 Marburg Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung
DE3230849A1 (de) * 1982-08-19 1984-02-23 Behringwerke Ag, 3550 Marburg Pasteurisiertes human-fibrinogen (hf) und verfahren zu dessen herstellung
US4927916A (en) * 1984-04-23 1990-05-22 The General Hospital Corporation Method of producing fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity using fibrin-specific peptides
US5357042A (en) * 1984-04-23 1994-10-18 The General Hospital Corporation Synthetic peptides capable of eliciting fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity
DE3430906A1 (de) * 1984-08-22 1986-02-27 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur bestimmung von fibrinmonomer in plasma
US4627879A (en) * 1984-09-07 1986-12-09 The Trustees Of Columbia University In The City Of New York Fibrin adhesive prepared as a concentrate from single donor fresh frozen plasma
US4928603A (en) * 1984-09-07 1990-05-29 The Trustees Of Columbia University In The City Of New York Method of preparing a cryoprecipitated suspension and use thereof
US5223420A (en) * 1985-03-01 1993-06-29 Institut National De La Sante Et De La Recherche Medicale Elastin-based product, a procedure for its preparation and its biological applications; in particular as biomaterials and artificial supports
SE447579B (sv) * 1985-04-01 1986-11-24 Biopool Ab Solubiliserbar, fibrinbaserad komposition och anvendning av kompositionen vid bestemning av fibrinolysparametrar
DE3622642A1 (de) * 1986-07-05 1988-01-14 Behringwerke Ag Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
DD261844A1 (de) * 1986-07-09 1988-11-09 Adw Ddr Verfahren zur praezipitation von fibrinmonomeren
US4714457A (en) * 1986-09-15 1987-12-22 Robert Alterbaum Method and apparatus for use in preparation of fibrinogen from a patient's blood
DK475386D0 (da) * 1986-10-03 1986-10-03 Weis Fogh Ulla Sivertsen Fremgangsmaade og apparat til fremstilling af biologiske stoffer
US4915847A (en) * 1987-08-04 1990-04-10 Baxter International Inc. Cryoglobulin separation
GB8628398D0 (en) * 1986-11-27 1986-12-31 Central Blood Lab Authority Pharmaceutically-active conjugates
US4709037A (en) * 1987-02-17 1987-11-24 Hoechst Celanese Corporation Biotinylating agents
US5175087A (en) * 1987-07-06 1992-12-29 Biopool International, Inc. Method of performing tissue plasminogen activator assay
DE3808048A1 (de) * 1988-03-11 1989-09-21 Behringwerke Ag Verfahren zum affinitaetschromatografischen reinigen von faktor xiii
US5290552A (en) * 1988-05-02 1994-03-01 Matrix Pharmaceutical, Inc./Project Hear Surgical adhesive material
AT397203B (de) * 1988-05-31 1994-02-25 Immuno Ag Gewebeklebstoff
DE3819923A1 (de) * 1988-06-11 1989-12-21 Behringwerke Ag Fibrin(ogen)derivate, verfahren zu ihrer herstellung und ihre verwendung
JPH03501777A (ja) * 1988-10-17 1991-04-18 モレキユラー　デヴアイシズ　コーポレイシヨン ハプテン誘導捕獲膜及び該膜を使用する診断アツセイ法
JPH02129234A (ja) * 1988-11-09 1990-05-17 Kanebo Ltd 難燃性フェノール系樹脂プリプレグ
JPH02129224A (ja) * 1988-11-10 1990-05-17 Terumo Corp フィブリンの製造法
DE3900493A1 (de) * 1989-01-10 1990-07-12 Thomae Gmbh Dr K Verfahren zur bestimmung der fibrinolytischen gesamtaktivitaet im plasma
US5026785A (en) * 1989-05-12 1991-06-25 The United States Of America As Represented By The Department Of Health And Human Services Avidin and streptavidin modified water-soluble polymers such as polyacrylamide, and the use thereof in the construction of soluble multivalent macromolecular conjugates
CA1335361C (fr) * 1989-05-24 1995-04-25 Andrei Z. Budzynski Complexes diriges contre les thrombus et formes d'activateurs du plasminogene et de fragments de fibrine
US5226877A (en) * 1989-06-23 1993-07-13 Epstein Gordon H Method and apparatus for preparing fibrinogen adhesive from whole blood
FR2649982B1 (fr) * 1989-07-20 1991-09-27 Inst Nat Sante Rech Med Membrane biologique artificielle
ES2062394T3 (es) * 1989-09-29 1994-12-16 Rohm & Haas Medio que contiene un ligando para la separacion cromatografica, procedimiento para la preparacion del medio y uso del medio para aislar moleculas naturales o sinteticas de una mezcla liquida.
US5252743A (en) * 1989-11-13 1993-10-12 Affymax Technologies N.V. Spatially-addressable immobilization of anti-ligands on surfaces
US5030215A (en) * 1990-01-03 1991-07-09 Cryolife, Inc. Preparation of fibrinogen/factor XIII precipitate
US5318524A (en) * 1990-01-03 1994-06-07 Cryolife, Inc. Fibrin sealant delivery kit
US5219328A (en) * 1990-01-03 1993-06-15 Cryolife, Inc. Fibrin sealant delivery method
US5185001A (en) * 1990-01-18 1993-02-09 The Research Foundation Of State University Of New York Method of preparing autologous plasma fibrin and application apparatus therefor
US5180828A (en) * 1990-02-09 1993-01-19 Molecular Devices Corporation Chromophoric reagents for incorporation of biotin or other haptens into macromolecules
US5420250A (en) * 1990-08-06 1995-05-30 Fibrin Corporation Phase transfer process for producing native plasma protein concentrates
AU644205B2 (en) * 1990-08-23 1993-12-02 New York Blood Center, Inc., The Assays using a soluble fibrin-like monomer
DE69127345D1 (de) * 1990-11-13 1997-09-25 Kyowa Hakko Kogyo Kk Mitomycinderivate
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
CH681693A5 (fr) * 1991-02-28 1993-05-14 Pentapharm Ag
EP0534178B1 (fr) * 1991-09-27 2001-04-18 Omrix Biopharmaceuticals S.A. Colle améliorée pour tissus préparée à partir de cryoprécipité
US5527692A (en) * 1991-12-31 1996-06-18 Zymogenetics, Inc. Methods for producing thrombin
US5272074A (en) * 1992-04-23 1993-12-21 Mcmaster University Fibrin coated polymer surfaces
US5443959A (en) * 1992-09-09 1995-08-22 Tokuyama Corporation Method of assaying fibrinogen, dry reagent therefor, and process for the preparation thereof
CN1091315A (zh) 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
US5292416A (en) * 1992-11-13 1994-03-08 Indiana University Foundation Pulsed-field separation of polysaccharides in capillaries
US5520885A (en) * 1993-01-19 1996-05-28 Thermogenesis Corporation Fibrinogen processing apparatus, method and container
US5330974A (en) * 1993-03-01 1994-07-19 Fibratek, Inc. Therapeutic fibrinogen compositions
JPH09502161A (ja) * 1993-03-12 1997-03-04 ジ・アメリカン・ナショナル・レッド・クロス 補足された及び補足されていない組織シーラント、その製造法及び使用法
US5464471A (en) * 1994-11-10 1995-11-07 Whalen Biomedical Inc. Fibrin monomer based tissue adhesive
US5510102A (en) * 1995-01-23 1996-04-23 The Regents Of The University Of California Plasma and polymer containing surgical hemostatic adhesives
EP0841108A1 (fr) * 1996-11-06 1998-05-13 Norsk Hydro ASA Procédé pour réaliser un raccordement entre des éléments métalliques

Also Published As

Publication number Publication date
ATE244581T1 (de) 2003-07-15
US5773418A (en) 1998-06-30
HUT66587A (en) 1994-12-28
SG49640A1 (en) 1998-06-15
EP0592242B1 (fr) 2003-07-09
PL176202B1 (pl) 1999-04-30
KR940008697A (ko) 1994-05-16
DE69333080D1 (de) 2003-08-14
EP1266666A3 (fr) 2003-01-22
DK0592242T3 (da) 2003-10-27
ES2065294A1 (es) 1995-02-01
US5962420A (en) 1999-10-05
US6077507A (en) 2000-06-20
NO314412B1 (no) 2003-03-17
AU4887893A (en) 1994-04-21
US5739288A (en) 1998-04-14
DE69333080T2 (de) 2004-04-15
JPH06199685A (ja) 1994-07-19
CN1091315A (zh) 1994-08-31
MX9306272A (es) 1994-07-29
NZ280264A (en) 1997-08-22
EP1266666A2 (fr) 2002-12-18
JP3771284B2 (ja) 2006-04-26
HU218898B (hu) 2000-12-28
US5770194A (en) 1998-06-23
US6262236B1 (en) 2001-07-17
FI934440A (fi) 1994-04-09
US6048966A (en) 2000-04-11
NZ328064A (en) 2000-08-25
CA2510981A1 (fr) 1994-04-09
ES2202306T3 (es) 2004-04-01
FI110616B (fi) 2003-02-28
CA2566574A1 (fr) 1994-04-09
US5763411A (en) 1998-06-09
HU9302839D0 (en) 1994-01-28
US5962026A (en) 1999-10-05
EP0592242A1 (fr) 1994-04-13
NO933624L (no) 1994-04-11
CZ211793A3 (en) 1996-04-17
CA2108104A1 (fr) 1994-04-09
RU2143924C1 (ru) 2000-01-10
BR9304185A (pt) 1994-05-03
FI934440A0 (fi) 1993-10-08
PL175443B1 (pl) 1998-12-31
NZ248897A (en) 1996-08-27
NO933624D0 (no) 1993-10-08
IL107211A0 (en) 1994-01-25
ES2065294B1 (es) 1995-11-01
SK109393A3 (en) 1994-06-08
US5750657A (en) 1998-05-12
US5804428A (en) 1998-09-08
US5763410A (en) 1998-06-09
AU676201B2 (en) 1997-03-06
CA2510981C (fr) 2007-02-13
CA2108104C (fr) 2005-09-27
PL173858B1 (pl) 1998-05-29
PT592242E (pt) 2003-11-28

Similar Documents

Publication Publication Date Title
IL107211A (en) Sealant compositions containing a fibrin monomer and methods and kits utilizing the same
RU93058414A (ru) Способы использования фибринового герметика, способ получения состава, составы, наборы
CA2151935A1 (fr) Compositions pour administration orale
AU7523294A (en) Concentrated liquid or gel dishwashing detergent composition containing calcium xylene sulfonate
AU1131592A (en) Laundry composition containing peroxyacid bleach and soil release agent
AU3678395A (en) Denture stabilizing compositions
NO302076B1 (no) Strålings-sensitive blokk-kopolymerer, fremgangsmåte for fremstilling av slike, og materialer som inneholder slike kopolymerer
AU581641B2 (en) Fluoroelastomer compositions containing fluoroaliphatic sulfonamides as curing agents
WO2000006658A3 (fr) Colles et produits d'etancheite
GR3017051T3 (en) Azeotropic or azeotropic-like composition of hydrochlorofluoropropane.
AU3410078A (en) High fluoride compatibility abrasives and compositions
EP0260869A3 (fr) Composition déodorisante
CA2150998A1 (fr) Composes derives du glycerol et du betaine pour le conditionnement des tissus
AU578065B2 (en) Stabilized enzyme conjugate compositions
GB9201452D0 (en) Single-component polysulphide based sealant compositions
AU3523589A (en) Novel iodinated non-ionic triiodobenzene compounds and contrast media containing them
AU628620B2 (en) Foliar glazing agent
AU7610194A (en) Thiocarbamoyl compounds used as antimicrobial agents
EP0347524A3 (fr) Bis(2,4-organylthio-s-triazin-6-yl)polysulphanes, procédé pour leur préparation et compositions vulcanisables les contenant
ZW12890A1 (en) Novel compound
AU531667B2 (en) Anaelobically curable sealing composition
RU93050548A (ru) Акриловая композиция, используемая в качестве уплотняющего состава или герметика
AU7104794A (en) Bridged carbapenem compounds, compositions and methods of use

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees